Skip to main content
NCBI home page
BMC Infectious Diseases logoLink to BMC Infectious Diseases
. 2008 Feb 29;8:24. doi: 10.1186/1471-2334-8-24

Comparative radiological features of disseminated disease due to Mycobacterium tuberculosis vs non-tuberculosis mycobacteria among AIDS patients in Brazil

Rodrigo P dos Santos 1,✉,#, Karin L Scheid 1,#, Denise MC Willers 1,#, Luciano Z Goldani 1,#
PMCID: PMC2270846  PMID: 18312647

Abstract

Background

Disseminated mycobacterial disease is an important cause of morbidity and mortality in patients with HIV-infection. Nonspecific clinical presentation makes the diagnosis difficult and sometimes neglected.

Methods

We conducted a retrospective cohort study to compare the presentation of disseminated Mycobacterial tuberculosis (MTB) and non-tuberculous Mycobacterial (NTM) disease in HIV-positive patients from 1996 to 2006 in Brazil.

Results

Tuberculosis (TB) was diagnosed in 65 patients (67.7%) and NTM in 31 (32.3%) patients. Patients with NTM had lower CD4 T cells counts (median 13.0 cells/mm3 versus 42.0 cells/mm3, P = 0.002). Patients with tuberculosis had significantly more positive acid-fast smears (48.0% vs 13.6%, P = 0.01). On chest X-ray, miliary infiltrate was only seen in patients with MTB (28.1% vs. 0.0%, P = 0.01). Pleural effusion was more common in patients with MTB (45.6% vs. 13.0%, P = 0.01). Abdominal adenopathy (73.1% vs. 33.3%, P = 0.003) and splenic hypoechoic nodules (38.5% vs. 0.0%, P = 0.002) were more common in patients with TB.

Conclusion

Miliary pulmonary pattern on X-ray, pleural effusion, abdominal adenopathy, and splenic hypoechoic nodules were imaging findings associated with the diagnosis of tuberculosis in HIV-infected patients. Recognition of these imaging features will help to distinguish TB from NTM in AIDS patients with fever of unknown origin due to disseminated mycobacterial disease.

Background

The use of highly active antiretroviral (HAART) therapy has been associated with a marked decrease in the incidence of opportunistic disease in patients with AIDS [1,2]. The incidence of non-tuberculous mycobacteria especially Mycobacterium avium complex (MAC) infections, the most common mycobacterial disease among immune compromised patients in developed countries [3,4], has dramatically declined since 1995 because of HAART [1,5]. For Mycobacterial tuberculosis (MTB) infections, this reduction was not so dramatic [6], but observational studies have demonstrated a protective effect of HAART in patients infected with MTB [7,8].

Universal access to antiretroviral medications has reduced the risk of tuberculosis in patients with AIDS in developing countries such as Brazil [9,10]. However, infections with MTB have reached endemic levels and continue to be a major public health problem in these countries [11,12]. Although previous mycobacterial infection has been associated with protection against subsequent mycobacterial infection [13], this is not always the rule [14]. On the other hand, the diagnosis of non-tuberculous mycobacterial (NTM) disease is still neglected in these settings considering its variable prevalence [3,4,13,15]. In Brazil, the rate of NTM disease can vary from 0% to 45% [11,16-18]. Mycobacterium avium complex is the major NTM specie identified in Brazil [19].

Rapid laboratorial detection of Mycobacterial species is difficult due to its dependence on the growth of usually slow growing mycobacteria. Speciation of a Mycobacterium isolate using these standard methods is a lengthy process based on subjective data interpretation. Commercially available molecular methods for speciation represent a useful and promising tool but are expensive and do not cover the number of mycobacteria that can be reliably identified in clinical laboratories. In addition, diagnosis based solely on the clinical presentation is unreliable considering that most HIV-infected patients with disseminated disease present systemic symptoms, such as fever, weight loss, and anorexia [20,21].

Abdominal and chest imaging are the initial steps in the investigation of fever of unknown origin (FUO) [22]. Considering that mycobacterial infections are the most common cause of FUO in patients with AIDS [23,24], radiological manifestations might be an important clue for the early diagnosis of tuberculosis (TB) or NTM disease in HIV-infected patients.

The goal of our study was to determine the most common radiological findings in patients with AIDS and disseminated mycobacterial disease caused by NTM and MTB in a tertiary care-hospital in Brazil.

Methods

We performed a retrospective cohort study at Hospital de Clínicas de Porto Alegre, a 735-bed accommodation tertiary-care hospital located in southern Brazil. From 1996 to 2006 all patients with the diagnosis of HIV infection and disseminated mycobacterial disease were included in the study. Patients were selected by the review of data from the records of microbiology laboratory.

Disseminated disease was characterized when we had a positive identification of MTB or NTM in either one of the following cultures: blood, bone marrow, or liver biopsies. For isolation of Mycobacterium sp. a radiometric system (BACTEC 460 TB – Becton & Dickinson Diagnostic Instrument Systems, Sparks, MD, USA), and non-radiometric systems (BACTEC 9240 – Becton & Dickinson Diagnostic Instrument Systems, Sparks, MD, USA; and, BacT/Alert 240 – bioMérieux, Marcy-lEtoile, France) were used. For identification of MTB or NTM, NAP (p-nitro-alfa-acetylamino-beta-hydroxypropiophenone) test was performed [25,26]. This test is highly specific for the identification of Mycobacterium tuberculosis complex (99%) [27]. In cases which NAP test could not be done, the identification of species were made by the visualization of the aspect of the colony – presence or absence of cord formation in liquid media – due to the high sensitivity and specificity of this method [28,29]. We did not use DNA probes for speciation of mycobacteria.

We included for analysis, the most recent CD4 lymphocyte count and HIV viral load test in a six-month period before the hospital arrival.

The imaging studies included – chest X-ray, abdominal ultrasound or computerized tomography (CT) – referred only to exams performed during the first 21 days of the patient's hospital stay.

A descriptive analysis of all the variables collected from each patient was performed. The chi-squared test or Ficher's exact test was used for univariate analysis of selected variables. Associations were considered statistically significant when P value was < 0.05. Data were compiled using Epi-Info 6.04 version and analyzed in SPSS 11.5 version program.

The ethic committee of Hospital de Clínicas de Porto Alegre approved the study. The authors signed a written commitment to guarantee the confidentiality of the data retrospectively collected.

Results

One-hundred and seven patients with disseminated mycobacterial disease were identified from 1996 to 2006. Eleven patients were excluded from the comparative analysis: six (5.6%) for incomplete data registry, three (2.8%) for simultaneous diagnosis of TB and NTM disease, and two (1.9%) because of lack of species identification. From the 96 remaining patients, disseminated TB was diagnosed in sixty-five patients (67.7%), and thirty-one (32.3%) had NTM disease.

The characteristics of patients with TB and NTM are shown in Table 1. A lower CD4 lymphocyte count was associated with NTM infection. Black race was associated with the diagnosis of TB. Patients with NTM were more exposed or were on use of HAART than patients with TB (57.6% versus 25.8%; P = 0.004). There was no significant difference between TB group and NTM group with respect to any other parameter. None of the patients were on MAC chemoprophylaxis. And none of the patients had the diagnosis of IRIS (immune reconstitution inflammatory syndrome).

Table 1.

Demographic characteristics of the HIV-infected patients with disseminated Mycobacterial disease

All Patients1 (n = 96) MTB (n = 65) NTM (n = 31) P
Age 32.0 32.0 34.0 .43
Men 71 (74.0) 49 (75.4) 22 (71.0) .83
Race2 .05
 White 63 (66.3) 39 (60.9) 24 (77.4)
 Black 23 (24.2) 20 (31.3) 3 (9.7)
 Other 9 (9.5) 5 (7.8) 4 (12.9)
HIV exposure .34
 Sexual 46 (57.5) 28 (52.8) 18 (56.7)
 IV drug use 34 (42.5) 25 (47.2) 9 (33.3)
Previous ART 35 (36.4) 17 (25.8) 18 (57.6) .004
Median CD4 (cels/mm3) (No. of patients) (53) 42.0 (34) 13.0 (19) .002
Median viral load (log/mL) (No. of patients) 5.2 (11) 4.7 (5) 5.4 (6) .83
Anti-HCV positive 26 (35.6) 18 (37.5) 8 (32.0) .83
HBsAg positive 6 (8.8) 4 (8.5) 2 (9.5) .74
Open in a new tab

Note. Data are no. (%) of patients, unless otherwise indicated. MTB, Mycobacterium tuberculosis; NTM, non-tuberculous mycobacteria; IV, intravenous; ART, antiretroviral therapy.

1 Patients diagnosed with tuberculosis and non-tuberculous mycobacteria infection.

2 P value related to black and white race groups comparison.

Our study confirms the high sensitivity and specificity of the presence of cord formation [28,29]. Considering the culture as the gold standard, sixty-four of 65 patients with TB had the presence of cord formation (sensitivity of 98%) and 30 of 31 patients with NTM disease had non-cord formation (specificity of 96%) by the visualization of the aspect of the colony.

There was no statistical significant difference comparing the clinical presentation in both groups of patients. The most common clinical symptoms were as follows: weight loss (92.7%), fever (89.6%), respiratory symptoms (75.0%), such as cough, hemoptysis, shortness of breath, and chest pain, and gastrointestinal manifestations (68.8%).

Only 27 patients had positive results on acid-fast smear on sputum or bronchoalveolar lavage, of these, twenty-four (48.0%) in the TB group and three (13.6%) in NTM infection group (P = 0.01).

The chest films and abdominal ultrasound or CT findings are shown in Table 2 and 3, respectively. The chest X-ray was normal in ten (13.2%) patients, while in abdominal image the result was normal in five (7.7%). There was no difference in terms of presence or absence of positive findings on chest X-ray or abdominal imaging comparing the patients with MTB or NTM disease. Seven patients (24.0%) with NTM infection and five (8.0%) patients with tuberculosis had normal chest X-ray findings (P = 0.07). One patient (4.5%) with NTM and three patients (5.5%) with MTB infection had normal abdominal findings on ultrasound or CT (P = 0.68).

Table 2.

Chest X-ray abnormalities in HIV-infected patients with disseminated mycobacterial disease

All Patients1 (n = 80) MTB (n = 57) NTM (n = 23) P
Diffuse infiltrate 41 (51.3) 28 (49.1) 13 (56.5) .72
Consolidation 30 (37.5) 21 (36.8) 9 (39.1) .92
Pleural effusion 29 (36.3) 26 (45.6) 3 (13.0) .001
Adenopathy 25 (31.3) 21 (36.8) 4 (17.4) .15
Miliary infiltrate 16 (20.0) 16 (28.1) 0 (0.0) .001
Atelectasis 3 (3.8) 2 (3.5) 1 (4.3) .63
Cardiomegaly 3 (3.8) 2 (3.5) 1 (4.3) .63
Cavitation 3 (3.8) 3 (5.3) 0 (0.0) .63
Nodules 3 (3.8) 3 (5.3) 0 (0.0) .63
Open in a new tab

Note. Data are no. (%) of patients, unless otherwise indicated. MTB, Mycobacterium tuberculosis; NTM, non-tuberculous mycobacteria.

1 Patients diagnosed with tuberculosis, and non-tuberculous mycobacteria infection.

Table 3.

Abdominal imaging by ultrasound or abdominal CT in HIV-infected patients with disseminated mycobacterial disease

All patients1 (n = 73) MTB (n = 52) NTM (n = 21) P
Adenopathy 45 (61.6) 38 (73.1) 7 (33.3) .003
Hepatomegaly 30 (41.1) 19 (36.5) 11 (52.4) .32
Ascities 25 (34.2) 18 (34.6) 7 (33.3) .86
Splenic hypodensities 20 (27.4) 20 (38.5) 0 (0.0) .002
Hepatosplenomegaly 20 (27.4) 15 (28.8) 5 (23.8) .88
Biliary tract alterations 19 (26.0) 12 (23.1) 7 (33.3) .54
Splenomegaly 18 (24.7) 13 (25.0) 5 (23.8) .84
Liver echotexture alteration 13 (17.8) 7 (13.5) 6 (28.6) .86
Liver hypodensities 8 (11.0) 5 (9.6) 3 (14.3) .74
Pancreatic lesions 3 (4.1) 3 (5.8) 0 (0.0) .63
Intestinal abnormalities 2 (2.7) 2 (3.8) 0 (0.0) .90
Abdominal Abscess 1 (1.4) 1 (1.9) 0 (0.0) .63
Open in a new tab

Note. Data are no. (%) of patients, unless otherwise indicated. MTB, Mycobacterium tuberculosis; NTM, non-tuberculous mycobacteria.

1 Patients diagnosed with tuberculosis, and non-tuberculous mycobacteria infection.

The most common findings on chest X-ray of HIV-infected patients with disseminated mycobacterial disease were pulmonary interstitial infiltrate (51.3%), consolidation (37.5%), pleural effusion (36.3%), and adenopathy (31.3%). On abdominal image, adenopathy (61.6%), hepatomegaly (41.1%), ascites (34.2%), and splenic hypodense lesions (27.4%) were the most common abnormalities described. Micronodular infiltrate was identified in sixteen patients (28.1%) with MTB infection and in none with NTM disease (P = 0.01). Pleural effusion was more common in patients with TB (45.6% vs 13.0%. P = 0.01). Other chest X-ray abnormalities were similar in both groups. Abdominal adenopathy was more frequent in patients with disseminated TB (73.1%, n = 38) than patients with NTM disease (33.3%, n = 7; P = 0.003). Only patients with MTB infection presented splenic hypodense lesions (38.5%; n = 20; P = 0.002). Other abdominal findings were associated with neither TB nor NTM infection.

When patients were stratified for the lowest CD4 lymphocyte count strata (CD4 ≤ 50 cels/mm3), all the imaging abnormalities previously associated to the diagnosis of disseminated TB (miliary infiltrate, pleural effusion, abdominal adenopathy, and splenic hypodense nodules) remained statistically significant for this diagnosis.

Discussion

We identified relevant imaging features that could help to distinguish TB from NTM in patients with AIDS and disseminated mycobacterial disease. The presence splenic hypoechoic nodules or micronodules suggestive of splenic microabscesses on abdominal ultrasound and CT scan were highly specific for TB in HIV-patients with disseminated mycobacterial disease, considering it was not seen in patients with NTM infection. Studies have demonstrated a higher prevalence of splenic lesions in HIV-infected patients with disseminated TB compared with those with disseminated NTM [30,31]. Bernabeu-Wittel et al have shown, in 36 patients with HIV infection and splenic microabscesses, that TB and NTM were the aetiology of 43% and 15% of patients respectively [30]. Radin found that 30% of patients with tuberculosis and 7% of patients with MAC had focal lesions in the spleen [31].

Previous non-comparative studies [32,33] have shown the association between TB and abdominal adenopathy. Monill-Serra, for instance, found that out of 76 patients with TB, twenty-seven had the presence of retroperitoneal and mesenteric adenopathy on sonographic imaging. Although some authors have advocated that virtually 100% of HIV-infected patients with MAC presented abdominal adenopathy [31,34,35], in our population the presence of adenopathy were predominantly seen in HIV-infected patients with TB.

Considering intrathoracic adenopathy, Jasmer et al [36] evaluated the imaging features of 318 HIV-infected patients, mostly with disseminated mycobacterial disease. The majority of HIV-infected patients (74%) diagnosed with TB had intrathoracic adenopathy on chest CT scan compared with 50% of the patients with NTM infection. The data did not demonstrate statistically significant difference in our patients, probably because we evaluated only the chest X-rays in contrast to CT scan, which has a higher sensitivity for the detection of intrathoracic adenopathy.

Miliary infiltrate was highly associated with diagnosis of TB. Considering that our HIV-infected patients with NTM did not present miliary pattern on chest X-ray. Hsieh et al [37] have found that none of their HIV-infected patients with MAC presented miliary pattern on chest X-ray. However, three HIV-infected patients with TB presented with miliary infiltrate on chest x-ray.

In patients with AIDS, atypical radiographic presentation of TB in severe immunossuppressed patients seems to occur frequently, and an interstitial diffuse infiltrate is one of the most common radiographic abnormality [37], as described in our patients. Significant pulmonary involvement has not been seen commonly in disseminated MAC infection [38], and a miliary pattern on X-ray is rarely seen in these patients [39-42]. It has been mostly reported in patients with infection by non-tuberculous mycobacteria other than MAC such as patients with Mycobacterium xenopi infection [43]. However, consolidations or nodular infiltrates, interstitial infiltrate, pulmonary mass and cavitation have been occasionally reported in HIV-infected patients with MAC infection [42]. In patients with AIDS and disseminated mycobacterial infection, the presence of pulmonary disease and miliary changes on X-ray strongly suggests the diagnosis of TB.

We have found that pleural effusion was associated with the diagnosis of TB. In contrast to disseminated MAC disease, pleural effusions have been frequently described in patients with disseminated TB. In fact, Hsieh et al, found no patient with MAC and pleural effusion in their study [37].

Infections due to MAC are related to more immunossupressed states [44,45]. Whereas MTB infections can affect patients with higher levels of CD4 counts, and is associated with a greater inflammatory response and granuloma formation. In our study, HIV-infected patients with disseminated TB had a higher median CD4 lymphocyte count compared with patients with disseminate NTM. However when we controlled our results for the lowest CD4 count strata (CD4 < 50 cels/mm3), all the imaging differences associated with the diagnosis of TB remained statistically significant. Some have advocated that the manifestations of TB in abdomen are related to the immunologic state of the patient [34,35], our data suggest that even in the lowest strata of CD4 counts, patients with TB still seem to have more exuberant disease presentation with abdominal adenopathy and granuloma formation than NTM disease.

Of interest, the sensitivity of acid-fast smears for the diagnosing disseminated disease was low in our patients with disseminated NTM and tuberculosis mycobacteria. Smith et al. have shown that positive acid-fast smears were frequently found in patients with disseminated tuberculosis disease and HIV (96%), and there was no difference related to HIV-status or level of immunossupression to the yield of acid-fast sputum smears [46]. Samb et al. evaluated factors associated with negative sputum smears in patients with disseminated TB and pulmonary involvement: absence of cavitation, lack of cough, HIV seropositivity, CD4 count above 200 cels/mm3, and age over 40 years was associated with smear negativity [47]. In disseminated MAC infection, the sensitivity of acid-fast smears and cultures from the respiratory tract is characteristically low [48]. Besides the low sensitivity for diagnosing TB and MAC in HIV-infected patients, the specificity of the acid-fast smear for the diagnosis of TB in our study was 83%, compared to patients with NTM disease.

Conclusion

In summary, miliary pulmonary pattern, pleural effusion, abdominal adenopathy, and splenic hypoechoic nodules were imaging findings associated with the diagnosis of disseminated tuberculosis in HIV-infected patients. Although the retrospective source of data, our results emphasize the importance of imaging studies as valuable tool to help differentiate MTB and NTM disseminated infections in HIV-infected patients, considering the similar clinical presentation of both diseases. Recognition of these imaging features can lead to a tentative diagnosis so that appropriate therapy can be instituted before the results of mycobacterial cultures become available.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

RPS: conceived of the study, participated in the design of the study, participated in data collection and wrote the manuscript.

KLS: participated in data collection and helped to draft the manuscript.

DMCW: helped to draft the manuscript.

LZG: conceived of the study, participated in the design and coordination of the study, helped to draft the manuscript.

All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-2334/8/24/prepub

Acknowledgments

Acknowledgements

We would like to thank FIPE (Hospital de Clínicas de Porto Alegre, Brazil) for partial support of this study.

Contributor Information

Rodrigo P dos Santos, Email: rpsrodrigo@gmail.com.

Karin L Scheid, Email: karinscheid@terra.com.br.

Denise MC Willers, Email: dwillers@hcpa.ufrgs.br.

Luciano Z Goldani, Email: rsf4805@via-rs.net.

References

  1. Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860. doi: 10.1056/NEJM199803263381301. [DOI] [PubMed] [Google Scholar]
  2. Forrest DM, Seminari E, Hogg RS, Yip B, Raboud J, Lawson L, Phillips P, Schecter MT, O'Shaughnessy MV, Montaner JS. The incidence and spectrum of AIDS-defining illness in persons treated with antiretroviral drugs. Clin Infect Dis. 1998;27:1379–1385. doi: 10.1086/515030. [DOI] [PubMed] [Google Scholar]
  3. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis. 1992;165:1082–1085. doi: 10.1093/infdis/165.6.1082. [DOI] [PubMed] [Google Scholar]
  4. Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Incidence and natural history of Mycobacterium avium-complex in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. Rev Respir Dis. 1992;146:285–289. doi: 10.1164/ajrccm/146.2.285. [DOI] [PubMed] [Google Scholar]
  5. Kaplan JE, Hanson D, Dworkin MS, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infec Dis. 2000;30:S5–14. doi: 10.1086/313843. [DOI] [PubMed] [Google Scholar]
  6. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS. 1997;11:1731–1738. doi: 10.1097/00002030-199714000-00010. [DOI] [PubMed] [Google Scholar]
  7. Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA. 1999;282:2220–2226. doi: 10.1001/jama.282.23.2220. [DOI] [PubMed] [Google Scholar]
  8. Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, Matteelli A, Ippolito G, Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA) Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS. 2000;14:1985–1991. doi: 10.1097/00002030-200009080-00015. [DOI] [PubMed] [Google Scholar]
  9. Marins JR, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA, Chequer P, Teixeira PR, Hearst N. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS. 2003;17:1675–1682. doi: 10.1097/00002030-200307250-00012. [DOI] [PubMed] [Google Scholar]
  10. Santoro-Lopes G, de Pinho AM, Harrison LH, Schecter M. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infections treated with highly active antiretroviral therapy. Clin Infect Dis. 2002;34:543–546. doi: 10.1086/338641. [DOI] [PubMed] [Google Scholar]
  11. Bacha HA, Cimerman S, de Souza SA, Hadad DJ, Mendes CM. Prevalence of mycobacteremia in patients with AIDS and persistent fever. Braz J Infect Dis. 2004;8:290–295. doi: 10.1590/S1413-86702004000400004. [DOI] [PubMed] [Google Scholar]
  12. DeRiemer K, Soares EC, Dias SM, Cavalcante SC. HIV testing among tuberculosis patients in the era of antiretroviral therapy: a population-based study in Brazil. Int J Tuberc Lung Dis. 2000;4:519–527. [PubMed] [Google Scholar]
  13. Fordham von Reyn C, Arbeit RD, Tosteson AN, Ristola MA, Barber TW, Waddell R, Sox CH, Brindle RJ, Gilks CF, Ranki A, Bartholomew C, Edwards J, Falkinham JO, 3rd, O'Connor GT. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group. AIDS. 1996;10:1025–1032. doi: 10.1097/00002030-199610090-00014. [DOI] [PubMed] [Google Scholar]
  14. Sterling TR, Moore RD, Graham NM, Astemborski J, Vlahov D, Chaisson RE. Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated Mavium complex disease. AIDS. 1998;12:1451–1457. doi: 10.1097/00002030-199812000-00006. [DOI] [PubMed] [Google Scholar]
  15. Crump JA, Reller LB. Two decades of disseminated tuberculosis at a university medical center: the expanding role of Mycobacterial blood culture. Clin Infect Dis. 2003;37:1037–1043. doi: 10.1086/378273. [DOI] [PubMed] [Google Scholar]
  16. Ferreira RM, Saad MH, Silva MG, Fonseca Lde S. Non-tuberculous mycobateria I: one year clinical isolates identification in Tertiary Hospital AIDS Reference Center, Rio de Janeiro, Brazil, in pre highly active antiretroviral therapy era. Mem Inst Oswaldo Cruz. 2002;97:725–729. doi: 10.1590/s0074-02762002000500024. [DOI] [PubMed] [Google Scholar]
  17. Gadelha A, Accacio N, Grinzstejn B, Veloso V, da Silveira LB, Fandinho F, Saad MH, Lourenço MC, Rolla V. Low incidence of colonization and no cases of disseminated Mycobacterium avium Complex infection (DMAC) in Brazilian AIDS patients in the HAART era. Braz J Infect Dis. 2002;6:252–257. doi: 10.1590/S1413-86702002000500006. [DOI] [PubMed] [Google Scholar]
  18. de C Ramos M, Vilares MC, Jacques de Moraes M, Calusni AL, Roscani GN, Piccoli Alves E. A retrospective bacteriological study of mycobacterial infections in patients with acquired immune deficiency syndrome (AIDS) Braz J Infect Dis. 2000;4:86–90. [PubMed] [Google Scholar]
  19. Ferreira RM, Saad MH, Silva MG, Fonseca Lde S. Non-tuberculous mycobacteria I: One year clinical isolates identification in tertiary hospital Aids reference center, Rio de Janeiro, Brazil, in pre highly active antiretroviral therapy era. Mem Inst Oswaldo Cruz. 2002;97:725–729. doi: 10.1590/s0074-02762002000500024. [DOI] [PubMed] [Google Scholar]
  20. Goodman PC. Mycobacterial disease in AIDS. J Thorac Imaging. 1991;6:22–27. doi: 10.1097/00005382-199109000-00007. [DOI] [PubMed] [Google Scholar]
  21. Horsburgh CR, Jr, Gettings J, Alexander LN, Lennox JL. Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985–2000. Clin Infect Dis. 2001;33:1938–1943. doi: 10.1086/324508. [DOI] [PubMed] [Google Scholar]
  22. Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med. 2003;163:545–551. doi: 10.1001/archinte.163.5.545. [DOI] [PubMed] [Google Scholar]
  23. Armstrong WS, Katz JT, Kazanjian PH. Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis. 1999;28:341–345. doi: 10.1086/515138. [DOI] [PubMed] [Google Scholar]
  24. Lambertucci JR, Rayes AA, Nunes F, Landazuri-Palacios JE, Nobre V. Fever of undetermined origin in patients with the acquired immunodeficiency syndrome in Brazil: report on 55 cases. Rev Inst Med Trop Sao Paulo. 1999;41:27–32. doi: 10.1590/s0036-46651999000100006. [DOI] [PubMed] [Google Scholar]
  25. Kiehn TE, Cammarata R. Laboratory diagnosis of mycobacterial infections in patients with acquired syndrome. J Clin Microbiol. 1986;24:708–711. doi: 10.1128/jcm.24.5.708-711.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Crump JA, Tanner DC, Mirrett S, McKnight CM, Reller LB. Controlled comparison of BACTEC 13A, MYCO/F LYTIC, BacT/ALERT MB, and ISOLATOR 10 systems for detection of mycobacteremia. J Clin Microbiol. 2003;41:1987–1990. doi: 10.1128/JCM.41.5.1987-1990.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Morgan MA, Doerr KA, Hempel HO, Goodman NL, Roberts GD. Evaluation of the p-Nitro-α-Acetylamnino-β-Hydroxypropiophenone differential test for identification of Mycobacterium tuberculosis complex. J Clin Microbiol. 1985;21:634–635. doi: 10.1128/jcm.21.4.634-635.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Koksalan OK, Aydin MD, Eraslan S, Bekiroglu N. Reliability of cord formation in BACTEC 12B/13A media for presumptive identification of Mycobacterium tuberculosis complex in laboratories with a high prevalence of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis. 2002;21:314–317. doi: 10.1007/s10096-002-0701-9. [DOI] [PubMed] [Google Scholar]
  29. Badak FZ, Goksel S, Sertoz R, Guzelant A, Kizirgil A, Bilgic A. Cord formation in MB/BacT medium is a reliable criterion for presumptive identification of Mycobacterium tuberculosis complex in laboratories with high prevalence of M. tuberculosis. J Clin Microbiol. 1999;37:4189–4191. doi: 10.1128/jcm.37.12.4189-4191.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Bernabeu-Wittel M, Villanueva JL, Pachon J, Alarcón A, López-Cortés LF, Viciana P, Cadaval F, Talegón A. Etiology, clinical features and outcome of splenic microabscesses in HIV-infected patients with prolonged fever. Eur J Clin Microbiol Infect Dis. 1999;18:324–329. doi: 10.1007/PL00015013. [DOI] [PubMed] [Google Scholar]
  31. Radin DR. Intraabdominal Mycobacterium tuberculosis vs Mycobacterium avium-intracellulare infections in patients with AIDS: distinction based on CT findings. AJR Am J Roentgenol. 1991;156:487–491. doi: 10.2214/ajr.156.3.1899742. [DOI] [PubMed] [Google Scholar]
  32. Monill-Serra JM, Martinez-Noguera A, Montserrat E, Maideu J, Sabaté JM. Abdominal ultrasound findings of disseminated tuberculosis in AIDS. J Clin Ultrasound. 1997;25:1–6. doi: 10.1002/(SICI)1097-0096(199701)25:1<1::AID-JCU1>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
  33. Monill JM, Franquet T, Sambeat MA, Martínez-Noguera A, Villalba J. Mycobacterium genavense infection in AIDS: imaging findings in eight patients. Euro Radiol. 2001;11:193–196. doi: 10.1007/s003300000606. [DOI] [PubMed] [Google Scholar]
  34. Koh DM, Burn PR, Mathews G, Nelson M, Healy JC. Abdominal computed tomographic findings of Mycobacterium tuberculosis and Mycobacterium avium intracellulare infection in HIV seropositive patients. Can Assoc Radiol J. 2003;54:45–50. [PubMed] [Google Scholar]
  35. Carucci LR, Halvorsen RA. Abdomen and pelvic CT in HIV- positive population. Abdom imaging. 2004;29:631–642. doi: 10.1007/s00261-004-0180-9. [DOI] [PubMed] [Google Scholar]
  36. Jasmer RM, Gotway MB, Creasman JM, Webb WR, Edinburgh KJ, Huang L. Clinical and radiographic predictors of the etiology of the computed tomography-diagnose intrathoracic lymphadenopathy in HIV-infected patients. Acquir Immune Defic Syndr. 2002;31:291–298. doi: 10.1097/00126334-200211010-00004. [DOI] [PubMed] [Google Scholar]
  37. Hsieh SM, Hung CC, Chen MY, Hsueh PR, Chang SC, Luh KT. Clinical features and outcome in disseminated mycobacterial diseases in AIDS patients in Taiwan. AIDS. 1998;12:1301–307. doi: 10.1097/00002030-199811000-00011. [DOI] [PubMed] [Google Scholar]
  38. MacDonell KB, Glassroth J. Mycobacterium avium complex and other nontuberculous mycobacteria in patients with HIV infection. Semin Respir Infect. 1989;4:123–132. [PubMed] [Google Scholar]
  39. El-Solh AA, Nopper J, Abdul-Khoudoud MR, Sherif SM, Aquilina AT, Grant BJ. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS. Chest. 1998;114:138–145. doi: 10.1378/chest.114.1.138. [DOI] [PubMed] [Google Scholar]
  40. Fishman JE, Schwartz DS, Sais GJ. Mycobacterium kansasii spectrum of pulmonary infection in patients with AIDS: chest radiographic findings. Radiology. 1997;204:171–175. doi: 10.1148/radiology.204.1.9205241. [DOI] [PubMed] [Google Scholar]
  41. Pursner M, Haller JO, Berdon WE. Imaging features of Mycobacterium avium-intracellulare complex (MAC) in children with AIDS. Pediatr Radiol. 2000;30:426–429. doi: 10.1007/s002470050778. [DOI] [PubMed] [Google Scholar]
  42. Kalayjian RC, Toossi Z, Tomashefski JF, Jr, Carey JT, Ross JA, Tomford JW, Blinkhorn RJ., Jr Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS. Clin Infect Dis. 1995;20:1186–1194. doi: 10.1093/clinids/20.5.1186. [DOI] [PubMed] [Google Scholar]
  43. Bankier AA, Stauffer F, Fleischmann D, Kreuzer S, Strasser G, Mossbacher U, Mallek R. Radiographic findings in patients with acquired immunodeficiency syndrome, pulmonary infection, and microbiologic evidence of Mycobacterium xenopi. J Thorac Imaging. 1998;13:282–288. doi: 10.1097/00005382-199810000-00008. [DOI] [PubMed] [Google Scholar]
  44. Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis. 2004;4:557–565. doi: 10.1016/S1473-3099(04)01130-2. [DOI] [PubMed] [Google Scholar]
  45. Williams PL, Currier JS, Swindells S. Joint effects of HIV-1 RNA levels and CD4 lymphocytes cells on the risk of specific opportunistic infections. AIDS. 1999;13:1035–1044. doi: 10.1097/00002030-199906180-00006. [DOI] [PubMed] [Google Scholar]
  46. Smith RL, Yew K, Berkowitz KA, Aranda CP. Factors affecting the yield of acid-fast sputum smears in patients with HIV and tuberculosis. Chest. 1994;106:684–686. doi: 10.1378/chest.106.3.684. [DOI] [PubMed] [Google Scholar]
  47. Samb B, Sow PS, Kony S, Maynart-Badiane M, Diouf G, Cissokho S, Bâ D, Sané M, Klotz F, Faye-Niang MA, Mboup S, Ndoye I, Delaporte E, Hane AA, Samb A, Coulaud JP, Coll-Seck AM, Larouzé B, Murray JF. Risk factors for negative sputum acid-fast smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence. Int J Tuberc Lung Dis. 1999;3:330–336. [PubMed] [Google Scholar]
  48. Poropatich CO, Labriola AM, Tuazon CU. Acid-fast smear and culture of respiratory secretions, bone marrow, and stools as predictors of disseminated Mycobacterium avium complex infection. J Clin Microbiol. 1987;25:929–930. doi: 10.1128/jcm.25.5.929-930.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Infectious Diseases are provided here courtesy of BMC

RESOURCES